Browsing by Author "Jung, Elizabeth"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
- ItemSafety, Tolerability, Pharmacokinetics, and Immunogenicity of Motavizumab, a Humanized, Enhanced-Potency Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus Infection in At-Risk Children(LIPPINCOTT WILLIAMS & WILKINS, 2009) Abarca, Katia; Jung, Elizabeth; Fernandez, Pilar; Zhao, Liang; Harris, Brian; Connor, Edward M.; Losonsky, Genevieve A.; Motavizumab Study GrpBackground: Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection in young children. Motavizumab is an investigational humanized monoclonal antibody for RSV prophylaxis.